Differences of HER2 Status by HercepTest and PATHWAY 4B5 Immunohistochemical Assays in Breast Cancer
{{output}}
Background/aim: Human epidermal growth factor receptor 2 (HER2) status assessment is subdivided according to trastuzumab-deruxtecan (T-DXd) suitability, and there is a discrepancy in HER2 staining depending on reagents. This stud... ...
